Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalfampridine for Cognition in Multiple Sclerosis
NCT02006160Phase 3Completed
- Sponsor
- University at Buffalo
- Start
- Dec 2011
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dalfampridine in multiple sclerosis (MS), sponsored by University at Buffalo. Started Dec 2011; status: completed.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02006160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02006160.